Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy
Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Numerous cathepsin B inhibitors have been developed and are under investigation as potential cancer treatments. They have been evaluated for their ability to inhibit cathepsin B activity and reduce tumor growth. However, they have shown critical limitations, including low anticancer efficacy and high toxicity, due to their low selectivity and deliv...
Alternative Titles
Full title
Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_82f51a022aca4129aa4541386587e74b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82f51a022aca4129aa4541386587e74b
Other Identifiers
ISSN
1999-4923
E-ISSN
1999-4923
DOI
10.3390/pharmaceutics15041131
